Prelude Capital Management’s Wright Medical Group, Inc. Contingent Value Right WMGIZ Stock Holding History

Prelude Capital Management’s Portfolio WMGIZ Stock Details WMGIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-28,001	Closed	-$43K	–	1999
2017 Q1	$43K	Hold	28,001	–	–	﹤0.01%	1074
2016 Q4	$37K	Hold	28,001	–	–	﹤0.01%	1139
2016 Q3	$37K	Hold	28,001	–	–	﹤0.01%	1141
2016 Q2	$35K	Hold	28,001	–	–	﹤0.01%	1127
2016 Q1	$35K	Hold	28,001	–	–	﹤0.01%	1034
2015 Q4	$29K	Buy	+28,001	New	+$28.5K	﹤0.01%	1152

Other funds holding WMGIZ

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Prelude Capital Management's WMGIZ Position: Q2 2017 in Review

Prelude Capital Management sold out of Wright Medical Group, Inc. Contingent Value Right (WMGIZ) in Q2 2017, closing a stake of 28,001 shares — an estimated $43K sold.

Prelude Capital Management first reported a position in WMGIZ in Q4 2015 and held it in 6 quarters. The position peaked at $43K in Q1 2017. 22 funds tracked by Wall St. Rank hold WMGIZ as of Q2 2017.

Prelude Capital Management reported no remaining Wright Medical Group, Inc. Contingent Value Right position as of Q2 2017 after selling out during the quarter.
Prelude Capital Management sold 28,001 Wright Medical Group, Inc. Contingent Value Right shares in Q2 2017, an estimated $43K.
Prelude Capital Management first reported a position in Wright Medical Group, Inc. Contingent Value Right in Q4 2015 and held it in 6 quarters.
Prelude Capital Management's Wright Medical Group, Inc. Contingent Value Right position peaked at $43K in Q1 2017.
22 funds tracked by Wall St. Rank held Wright Medical Group, Inc. Contingent Value Right as of Q2 2017.

Based on Prelude Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.